Home » Topics » BioWorld Science

BioWorld Science
RSS

Manufacturing agreement for Neoprobe's RIGS/ACT activated cell therapy

June 7, 1996

E. Merck describes immunoconjugates

June 7, 1996

Melanogenesis inhibitor revealed

June 7, 1996

Ongoing evaluation of Pharmacia & Upjohn's new water-soluble camptothecin derivative

June 7, 1996

New 5-FU molecular combination merits further study

June 7, 1996

Development of AccuSite for basal cell carcinoma delayed

June 7, 1996

S-28828: 3M's imiquimod analogue

June 7, 1996

Controlled-release naproxen sodium now on U.S. shelves

June 7, 1996

Organon develops potent inhibitor of alpha-glucosidase I

June 7, 1996

Anika Research seeks European marketing approval for Orthovisc

June 7, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...